Short-term effect of topical antiglaucoma medication on tear-film stability, tear secretion, and corneal sensitivity in healthy subjects

Naim Terai, Matthias Müller-Holz, Eberhard Spoerl, Lutz E PillunatDepartment of Ophthalmology, Carl Gustav Carus University Hospital, Dresden, GermanyBackground: The purpose of this study was to investigate the short-term effect of topical antiglaucoma medication on tear-film stability,...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Pillunat LE, Spoerl E, Müller-Holz M, Terai N
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2011
Materias:
Acceso en línea:https://doaj.org/article/f919bd69b03f4de7931e2a0d4a655a6b
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:f919bd69b03f4de7931e2a0d4a655a6b
record_format dspace
spelling oai:doaj.org-article:f919bd69b03f4de7931e2a0d4a655a6b2021-12-02T01:08:39ZShort-term effect of topical antiglaucoma medication on tear-film stability, tear secretion, and corneal sensitivity in healthy subjects1177-54671177-5483https://doaj.org/article/f919bd69b03f4de7931e2a0d4a655a6b2011-04-01T00:00:00Zhttp://www.dovepress.com/short-term-effect-of-topical-antiglaucoma-medication-on-tear-film-stab-a7233https://doaj.org/toc/1177-5467https://doaj.org/toc/1177-5483Naim Terai, Matthias Müller-Holz, Eberhard Spoerl, Lutz E PillunatDepartment of Ophthalmology, Carl Gustav Carus University Hospital, Dresden, GermanyBackground: The purpose of this study was to investigate the short-term effect of topical antiglaucoma medication on tear-film stability, tear secretion, and corneal sensitivity in healthy subjects.Methods: In this prospective, double-blind crossover trial, break-up time and basal secretion (Jones test) were measured 60 minutes before, and 30, 60, and 90 minutes after topical antiglaucoma drop application in 30 healthy subjects. Corneal sensitivity was measured 60 minutes before, and five, 10, and 15 minutes after drop application using a Cochet–Bonnet esthesiometer.Results: Reduction of break-up time in the latanoprost group was -23.8% after 30 minutes (P = 0.21), -26.7% after 60 minutes (P = 0.03) and -51.4% after 90 minutes (P ≤ 0.003), which was statistically significant. Reduction of break-up time in all other treatment groups was not statistically significant. The Jones test revealed a significant reduction of basal secretion after application of brimonidine (-17.8%, P = 0.002; -22.5%, P< 0.001; -30.5%, P < 0.001), followed by apraclonidine (-10%, P = 0.06; -20.1%, P = 0.02; -22.1%, P = 0.002), latanoprost (-2.4%, P = 0.64; -18.6%, P = 0.001; -20.1%, P = 0.001) and dorzolamide (-0.5%, P = 0.9; 14.3%, P = 0.018; -17.3%, P = 0.004) at 30, 60, and 90 minutes after drop application. Reduction of basal secretion in all other treatment groups was not statistically significant.Conclusion: Latanoprost showed the most statistically significant reduction in break-up time, and brimonidine showed the most significant reduction in basal secretion of all the glaucoma medications used in this study. In conclusion, our data may be helpful for treatment decisions in glaucoma patients who also suffer from ocular surface problems.Keywords: tear-film, tear secretion, corneal sensitivity, antiglaucoma medicationPillunat LESpoerl EMüller-Holz MTerai NDove Medical PressarticleOphthalmologyRE1-994ENClinical Ophthalmology, Vol 2011, Iss default, Pp 517-525 (2011)
institution DOAJ
collection DOAJ
language EN
topic Ophthalmology
RE1-994
spellingShingle Ophthalmology
RE1-994
Pillunat LE
Spoerl E
Müller-Holz M
Terai N
Short-term effect of topical antiglaucoma medication on tear-film stability, tear secretion, and corneal sensitivity in healthy subjects
description Naim Terai, Matthias Müller-Holz, Eberhard Spoerl, Lutz E PillunatDepartment of Ophthalmology, Carl Gustav Carus University Hospital, Dresden, GermanyBackground: The purpose of this study was to investigate the short-term effect of topical antiglaucoma medication on tear-film stability, tear secretion, and corneal sensitivity in healthy subjects.Methods: In this prospective, double-blind crossover trial, break-up time and basal secretion (Jones test) were measured 60 minutes before, and 30, 60, and 90 minutes after topical antiglaucoma drop application in 30 healthy subjects. Corneal sensitivity was measured 60 minutes before, and five, 10, and 15 minutes after drop application using a Cochet–Bonnet esthesiometer.Results: Reduction of break-up time in the latanoprost group was -23.8% after 30 minutes (P = 0.21), -26.7% after 60 minutes (P = 0.03) and -51.4% after 90 minutes (P ≤ 0.003), which was statistically significant. Reduction of break-up time in all other treatment groups was not statistically significant. The Jones test revealed a significant reduction of basal secretion after application of brimonidine (-17.8%, P = 0.002; -22.5%, P< 0.001; -30.5%, P < 0.001), followed by apraclonidine (-10%, P = 0.06; -20.1%, P = 0.02; -22.1%, P = 0.002), latanoprost (-2.4%, P = 0.64; -18.6%, P = 0.001; -20.1%, P = 0.001) and dorzolamide (-0.5%, P = 0.9; 14.3%, P = 0.018; -17.3%, P = 0.004) at 30, 60, and 90 minutes after drop application. Reduction of basal secretion in all other treatment groups was not statistically significant.Conclusion: Latanoprost showed the most statistically significant reduction in break-up time, and brimonidine showed the most significant reduction in basal secretion of all the glaucoma medications used in this study. In conclusion, our data may be helpful for treatment decisions in glaucoma patients who also suffer from ocular surface problems.Keywords: tear-film, tear secretion, corneal sensitivity, antiglaucoma medication
format article
author Pillunat LE
Spoerl E
Müller-Holz M
Terai N
author_facet Pillunat LE
Spoerl E
Müller-Holz M
Terai N
author_sort Pillunat LE
title Short-term effect of topical antiglaucoma medication on tear-film stability, tear secretion, and corneal sensitivity in healthy subjects
title_short Short-term effect of topical antiglaucoma medication on tear-film stability, tear secretion, and corneal sensitivity in healthy subjects
title_full Short-term effect of topical antiglaucoma medication on tear-film stability, tear secretion, and corneal sensitivity in healthy subjects
title_fullStr Short-term effect of topical antiglaucoma medication on tear-film stability, tear secretion, and corneal sensitivity in healthy subjects
title_full_unstemmed Short-term effect of topical antiglaucoma medication on tear-film stability, tear secretion, and corneal sensitivity in healthy subjects
title_sort short-term effect of topical antiglaucoma medication on tear-film stability, tear secretion, and corneal sensitivity in healthy subjects
publisher Dove Medical Press
publishDate 2011
url https://doaj.org/article/f919bd69b03f4de7931e2a0d4a655a6b
work_keys_str_mv AT pillunatle shorttermeffectoftopicalantiglaucomamedicationontearfilmstabilitytearsecretionandcornealsensitivityinhealthysubjects
AT spoerle shorttermeffectoftopicalantiglaucomamedicationontearfilmstabilitytearsecretionandcornealsensitivityinhealthysubjects
AT mampuumlllerholzm shorttermeffectoftopicalantiglaucomamedicationontearfilmstabilitytearsecretionandcornealsensitivityinhealthysubjects
AT terain shorttermeffectoftopicalantiglaucomamedicationontearfilmstabilitytearsecretionandcornealsensitivityinhealthysubjects
_version_ 1718403293873438720